Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Investigating ORF8-mediated immune evasion in SARS-CoV-2 variants of concern
FY 2021-22
Summary
The global spread of SARS-CoV-2 has led to significant viral evolution. A number of variants of concern (VOCs) have already been identified, among which Delta now dominates the COVID-19 landscape in many countries including Canada. Common to all VOCs are sets of naturally selected changes providing a fitness advantage for the virus. One of the fastest evolving sites is Open Reading Frame (ORF) 8, a protein present in COVID-19 patients blood whose numerous roles include contributing to cytokine storm seen in severe disease. ORF8 also mediates viral immune escape by downregulating key molecules necessary for immune cells to detect infection. One such molecule is Major Histocompatibility Complex I (MHC-I), a key player in clearing infections by presenting viral components on infected cells to then be targeted by immune cells. Also, I recently discovered that ORF8 downregulates Fc gamma receptor 1A (FcGR1A) present on immune cells that associates with antiviral antibodies to protect against infection. This reduction in MHC-1 and FcGR1A levels lets SARS-CoV-2 evade host immunity, yet whether this function is enhanced in VOCs is unknown. I therefore hypothesize that ORF8 mutations antagonizing immunity through MHC-1 and FcGR1A downregulation contribute to the increased pathogenesis of SARS-CoV-2 VOCs. This work aims to identify mutations enhanced in ORF8 of circulating VOCs and examine if and how they increasingly downregulate MHC-1 and FcGR1A in a cell model system. I believe the characterization of mutations in fast evolving sites like ORF8 is crucial to further elucidate the molecular basis for viral pathogenesis. Such work will inspire the development of antiviral therapies specifically targeting immune impairment to enhance SARS-CoV-2 surveillance by host immunity.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
467088
Name
Arduini Ariana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating ORF8-mediated immune evasion in SARS-CoV-2 variants of concern
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Accessory Protein; Emerging Virus; Fcgrs; Immune Evasion; Mhc-I; Orf8; Sars-Cov-2; Variants Of Concern; Virology
Abstract
The global spread of SARS-CoV-2 has led to significant viral evolution. A number of variants of concern (VOCs) have already been identified, among which Delta now dominates the COVID-19 landscape in many countries including Canada. Common to all VOCs are sets of naturally selected changes providing a fitness advantage for the virus. One of the fastest evolving sites is Open Reading Frame (ORF) 8, a protein present in COVID-19 patients blood whose numerous roles include contributing to cytokine storm seen in severe disease. ORF8 also mediates viral immune escape by downregulating key molecules necessary for immune cells to detect infection. One such molecule is Major Histocompatibility Complex I (MHC-I), a key player in clearing infections by presenting viral components on infected cells to then be targeted by immune cells. Also, I recently discovered that ORF8 downregulates Fc gamma receptor 1A (FcGR1A) present on immune cells that associates with antiviral antibodies to protect against infection. This reduction in MHC-1 and FcGR1A levels lets SARS-CoV-2 evade host immunity, yet whether this function is enhanced in VOCs is unknown. I therefore hypothesize that ORF8 mutations antagonizing immunity through MHC-1 and FcGR1A downregulation contribute to the increased pathogenesis of SARS-CoV-2 VOCs. This work aims to identify mutations enhanced in ORF8 of circulating VOCs and examine if and how they increasingly downregulate MHC-1 and FcGR1A in a cell model system. I believe the characterization of mutations in fast evolving sites like ORF8 is crucial to further elucidate the molecular basis for viral pathogenesis. Such work will inspire the development of antiviral therapies specifically targeting immune impairment to enhance SARS-CoV-2 surveillance by host immunity.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arduini, Ariana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~